204
Participants
Start Date
October 9, 2018
Primary Completion Date
March 15, 2019
Study Completion Date
March 15, 2019
Anaferon
Oral administration.
Placebo
Oral administration.
The Federal State Budgetary Healthcare Institution The Central Clinical Hospital of the Russian Academy of Sciences, Moscow
Pirogov Russian National Research Medical University, Moscow
"Federal State Institution Polyclinic No. 5 of the Administrative Department of the President of the Russian Federation", Moscow
Podolskaya City Clinical Hospital No. 3, Podolsk
Krasnogorsk city hospital №1, Krasnogorsk
Central City Clinical Hospital of Reutov, Reutov
Yaroslavl State Medical University, Yaroslavl
"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 25", Saint Petersburg
"St. Petersburg State Health Care Institution City Polyclinic №117", Saint Petersburg
Road Clinical Hospital JSC Russian Railways, Saint Petersburg
"LLC Research Center Eco-Security", Saint Petersburg
"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 51", Saint Petersburg
"St. Petersburg City State Hospital City Hospital No. 26", Saint Petersburg
"St. Petersburg State Budgetary Institution of Health City Polyclinic №34", Saint Petersburg
"Regional State Budgetary Healthcare Institution Clinical Hospital No.1", Smolensk
Saratov City Clinical Hospital № 2 named after VI Razumovsky, Saratov
Kazan State Medical University, Kazan'
"Non-governmental health care institution Road Clinical Hospital at Chelyabinsk station JSC Russian Railways ", Chelyabinsk
"Regional State Budgetary Healthcare Institution City Hospital No. 5, Barnaul", Barnaul
Lead Sponsor
Materia Medica Holding
INDUSTRY